Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism SLC7A5 inhibitors(L-type amino acid transporter 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Phase 2 | - | - | |
Brain Cancer | Phase 1 | - | - | |
Glioma | Phase 1 | US | - | |
Multiple Sclerosis | Phase 1 | - | - | |
Multiple Sclerosis | Phase 1 | US | - | |
Neuromyelitis Optica | Preclinical | US | 01 Nov 2024 |